Differential chemoreactome analysis of glucosamine sulfate and non-steroidal anti-inflammatory drugs: promising synergistic drug combinations

QR Code

Differential chemoreactome analysis of glucosamine sulfate and non-steroidal anti-inflammatory drugs: promising synergistic drug combinations

Glucosamine sulfate (GS) is essential for the regeneration of cartilaginous tissue and, in addition, it has anti-inflammatory properties comparable to those of nonsteroidal anti-inflammatory drugs (NSAIDs). Clinical trials indicate the synergism between GS and NSAIDs in osteoarthritis (OA) and other...

Full description

Saved in:

Bibliographic Details
Main Authors:	O. A. Gromova, I. Yu. Torshin, A. M. Lila, A. V. Naumov, I. A. Reier, A. E. Karateev
Format:	Article
Language:	Russian
Published:	IMA-PRESS LLC 2018-06-01
Series:	Современная ревматология
Subjects:	glucosamine sulfate sustaquard artro ketorolac nimesulide dexketoprofen meloxicam diclofenac celecoxib etoricoxib database mining
Online Access:	https://mrj.ima-press.net/mrj/article/view/823
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Chemoreactome analysis of the antithrombotic effects of glucosamine sulfate and nonsteroidal anti-inflammatory drugs
by: O. A. Gromova, et al.
Published: (2019-03-01)

On the anticoagulant and antiaggregatory properties of a glucosamine sulfate molecule
by: I. Yu. Torshin, et al.
Published: (2019-09-01)

The results of postgenomic analysis of a glucosamine sulfate molecule indicate the prospects of treatment for comorbidities
by: I. Yu. Torshin, et al.
Published: (2018-12-01)

Comparative clinical and economic analysis of the use of symptomatic slow-acting drugs containing glucosamine sulfate in patients with Stage II gonarthrosis during outpatient care
by: I. V. Sarvilina, et al.
Published: (2019-12-01)

Is it worthwhile rethinking the positive experience of the last 50 years of using chondroitin sulfates against atherosclerosis?
by: A. M. Lila, et al.
Published: (2020-08-01)

Histomorphological changes in thymus and spleen after cyclooxygenase inhibitors treatment
by: Poeta O.N., et al.
Published: (2009-01-01)

Chemomicrobiomic analysis of glucosamine sulfate, prebiotics and non-steroidal anti-inflammatory drugs
by: O. A. Gromova, et al.
Published: (2020-11-01)

Hepatoprotective effects of chondroitin sulfate and glucosamine sulfate
by: I. Yu. Torshin, et al.
Published: (2022-01-01)

Effect glucosamine sulfate drug on liver tissue of male Albino mice
by: Baghdad Science Journal
Published: (2015-06-01)

Quality of life characteristics in assessment of diclofenac and Nise® efficacy in patients with gonarthritis
by: L V Sizova, et al.
Published: (2003-08-01)

Perioperative pharmacotherapy for endoprosthetics: potential of chondroitin sulfate and glucosamine sulfate
by: I. Yu. Torshin, et al.
Published: (2022-04-01)

Prospects for the use of chondroitin sulfate and glucosamine sulfate in the treatment of patients with obesity-associated osteoarthritis (metabolic syndrome)
by: I. Yu. Torshin, et al.
Published: (2022-10-01)

Prospects for the use of chondroitin sulfate and glucosamine sulfate with osteoarthritis associated with pathology of the kidneys and urinary system
by: I. Yu. Torshin, et al.
Published: (2020-04-01)

Cardiovascular safety and efficacy of the combined symptomatic slow-acting drug glucosamine and chondroitin sulfate in patients with gonarthrosis
by: A. P. Rebrov, et al.
Published: (2016-06-01)

Efficacy and safety of the combined use of celecoxib, diacerein and a combination of glucosamine and chondroitin for the control of musculoskeletal pain associated with osteoarthritis and nonspecific back pain
by: A. E. Karateev, et al.
Published: (2023-10-01)

The efficacy and tolerability of the slow-acting combined agent glucosamine and chondroitin sulfate in gonarthrosis patients tacking no nonsteroidal anti-inflammatory drugs
by: A. P. Rebrov, et al.
Published: (2016-01-01)

Russian experience with injectable chondroitin sulfate and glucosamine sulfate: a review of clinical trials
by: A. E. Karateev, et al.
Published: (2018-04-01)

CURRENT PHARMACOTHERAPY FOR KNEE OSTEOARTHRITIS: SPECIFIC FEATURES OF SYMPTOMATIC AND DISEASE MODIFYING EFFECTS. COMMUNICATION 1. SPECIFIC FEATURES OF THE SYMPTOMATIC EFFECTS OF CURRENT DRUGS TO TREAT KNEE OSTHEOARTHRITIS
by: E. S. Tsvetkova, et al.
Published: (2015-03-01)

Chemoreactome screening of pharmaceutical effects on SARS-CoV-2 and human virome to help decide on drug-based COVID-19 therapy
by: I. Yu. Torshin, et al.
Published: (2021-07-01)

Comparison of Glucosamine-Chondroitin Sulfate with and without Methylsulfonylmethane in Grade I-II Knee Osteoarthritis: A Double Blind Randomized Controlled Trial
by: Andri M.T. Lubis, et al.
Published: (2017-08-01)

Comparison of Glucosamine-Chondroitin Sulfate with and without Methylsulfonylmethane in Grade I-II Knee Osteoarthritis: A Double Blind Randomized Controlled Trial
by: Andri M.T. Lubis, et al.
Published: (2017-08-01)

USE OF TOPICAL NON-STEROID ANTIINFLAMMATORY DRUGS IN PEDIATRIC PRACTICE
by: F. C. Shakhtatinskaya
Published: (2012-12-01)

Combined use of non-steroidal anti-inflammatory drugs and symptomatic slow-acting drugs in musculoskeletal diseases
by: A. E. Karateev, et al.
Published: (2023-07-01)

Evaluation of the efficacy and safety of a combination of chondroitin sulfate and glucosamine sulfate for knee and hip osteoarthritis in real clinical practice
by: A. E. Karateev, et al.
Published: (2020-11-01)

Preparation of 123-iodine labeled glucosamine derivative and investigation of its biological properties
by: M. S. Larkina, et al.
Published: (2018-03-01)

Evidence-based therapy for knee osteoarthritis: expected short-, medium-, and long-term outcomes of prescription crystalline glucosamine sulfate administration
by: L. N. Denisov, et al.
Published: (2022-08-01)

Therapy with non-steroidal anti-inflammatory drugs and the quality of life of patients with rheumatic diseases
by: E. Yu. Polishchuk, et al.
Published: (2022-02-01)

Suppression of acute bone marrow edema (osteitis) in the sacroiliac joints with long-term use of non-steroidal anti-inflammatory drugs in patients with axial spondyloarthritis
by: Sh. F. Erdes, et al.
Published: (2023-04-01)

Effect of multiple-dose regimens of cyclooxygenase inhibitors and their combinations with mexidol on behavior in mature rats
by: E. A. Ivanova, et al.
Published: (2023-05-01)

DEVELOPMENT AND VALIDATION THE METHOD OF QUANTITATIVE DETERMINATION OF ETORICOXIB IN SOLID PHARMACEUTICAL FORMS BY HPLC
by: T. L. Batalova, et al.
Published: (2019-01-01)

Osteoarthritis background therapy: current view on the glucosamine and chondroitin therapy
by: L. I. Alekseeva, et al.
Published: (2021-04-01)

Analgesic action of hexaazaisowurtzitane derivative in somatic pain models caused by TRPA1 and TRPV1 Ion channels activation
by: S. G. Krylova, et al.
Published: (2021-01-01)

USE OF NONSTEROIDAL ANTI-INFLAMMATORY DRUGS IN PATIENTS WITH HIGH CARDIOVASCULAR RISK
by: Yu. A. Olyunin
Published: (2017-07-01)

Use of etoricoxib in patients with gout in real clinical practice
by: M S Eliseyev, et al.
Published: (2013-06-01)

Experimental and Acomparative Study for the effect of GlucosAmine hydrochloride as Antioxidant in Sera of Adult Male Rabbits
by: Rafah Razooq Hameed Al- Samarrai, et al.
Published: (2023-02-01)

Treatment of osteoarthritis: A focus on nimesulide
by: G. R. Imametdinova, et al.
Published: (2017-04-01)

Regulation of the non-steroid anti-inflammatory drug «Diclofenac sodium» in the air environment of populated places
by: Ya.Yu. Nikolaieva
Published: (2025-06-01)

PENGARUH PEMBERIAN INJEKSI KETOROLAC INTRAPERITONEAL TERHADAP PENYEMBUHAN FRAKTUR KRURIS TIKUS WISTAR DEWASA
by: Ivandy Fam, et al.
Published: (2016-11-01)

A new view of the therapy of osteoarthrosis
by: T A Raskina, et al.
Published: (2012-12-01)

Standardised Forms of Chondroitin Sulfate as a Pathogenetic Treatment of Osteoarthritis in the Context of Post-Genomic Studies
by: O. A. Gromova, et al.
Published: (2021-02-01)